Long-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccine
- PMID: 25337803
- PMCID: PMC4206452
- DOI: 10.1371/journal.pone.0110883
Long-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccine
Abstract
Prevention of HIV acquisition and replication requires long lasting and effective immunity. Given the state of HIV vaccine development, innovative vectors and immunization strategies are urgently needed to generate safe and efficacious HIV vaccines. Here, we developed a novel lentivirus-based DNA vector that does not integrate in the host genome and undergoes a single-cycle of replication. Viral proteins are constitutively expressed under the control of Tat-independent LTR promoter from goat lentivirus. We immunized six macaques once only with CAL-SHIV-IN- DNA using combined intramuscular and intradermal injections plus electroporation. Antigen-specific T cell responses were monitored for 47 weeks post-immunization (PI). PBMCs were assessed directly ex vivo or after 6 and 12 days of in vitro culture using antigenic and/or homeostatic proliferation. IFN-γ ELISPOT was used to measure immediate cytokine secretion from antigen specific effector cells and from memory precursors with high proliferative capacity (PHPC). The memory phenotype and functions (proliferation, cytokine expression, lytic content) of specific T cells were tested using multiparametric FACS-based assays. All immunized macaques developed lasting peripheral CD8+ and CD4+ T cell responses mainly against Gag and Nef antigens. During the primary expansion phase, immediate effector cells as well as increasing numbers of proliferating cells with limited effector functions were detected which expressed markers of effector (EM) and central (CM) memory phenotypes. These responses contracted but then reemerged later in absence of antigen boost. Strong PHPC responses comprising vaccine-specific CM and EM T cells that readily expanded and acquired immediate effector functions were detected at 40/47 weeks PI. Altogether, our study demonstrated that a single immunization with a replication-limited DNA vaccine elicited persistent vaccine-specific CM and EM CD8+ and CD4+ T cells with immediate and readily inducible effector functions, in the absence of ongoing antigen expression.
Conflict of interest statement
Figures
Similar articles
-
HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates.J Virol. 2017 Apr 13;91(9):e02182-16. doi: 10.1128/JVI.02182-16. Print 2017 May 1. J Virol. 2017. PMID: 28179536 Free PMC article.
-
A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.AIDS Res Hum Retroviruses. 2008 Feb;24(2):207-17. doi: 10.1089/aid.2007.0206. AIDS Res Hum Retroviruses. 2008. PMID: 18240963
-
DNA-MVA vaccine protection after X4 SHIV challenge in macaques correlates with day-of-challenge antiviral CD4+ cell-mediated immunity levels and postchallenge preservation of CD4+ T cell memory.AIDS Res Hum Retroviruses. 2008 Mar;24(3):505-19. doi: 10.1089/aid.2007.0191. AIDS Res Hum Retroviruses. 2008. PMID: 18373436 Free PMC article.
-
A novel non-integrative single-cycle chimeric HIV lentivector DNA vaccine.Vaccine. 2015 May 5;33(19):2273-2282. doi: 10.1016/j.vaccine.2015.03.021. Epub 2015 Mar 28. Vaccine. 2015. PMID: 25825333
-
Multiple Approaches for Increasing the Immunogenicity of an Epitope-Based Anti-HIV Vaccine.AIDS Res Hum Retroviruses. 2015 Nov;31(11):1077-88. doi: 10.1089/AID.2015.0101. Epub 2015 Aug 13. AIDS Res Hum Retroviruses. 2015. PMID: 26149745 Review.
Cited by
-
Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine.Vaccines (Basel). 2024 Mar 18;12(3):322. doi: 10.3390/vaccines12030322. Vaccines (Basel). 2024. PMID: 38543955 Free PMC article.
-
Predictive Markers of Immunogenicity and Efficacy for Human Vaccines.Vaccines (Basel). 2021 Jun 1;9(6):579. doi: 10.3390/vaccines9060579. Vaccines (Basel). 2021. PMID: 34205932 Free PMC article. Review.
-
Cowpox Helped Against Smallpox; Will the Goat Lentivirus (Caprine Arthritis Encephalitis Virus) Help Against HIV-1?AIDS Res Hum Retroviruses. 2015 Jun;31(6):577-8. doi: 10.1089/aid.2015.0010. Epub 2015 Apr 6. AIDS Res Hum Retroviruses. 2015. PMID: 25844817 Free PMC article. No abstract available.
-
Cytokine Adjuvants IL-7 and IL-15 Improve Humoral Responses of a SHIV LentiDNA Vaccine in Animal Models.Vaccines (Basel). 2022 Mar 17;10(3):461. doi: 10.3390/vaccines10030461. Vaccines (Basel). 2022. PMID: 35335093 Free PMC article.
References
-
- Feinberg MB, Ahmed R (2012) Born this way? Understanding the immunological basis of effective HIV control. Nat Immunol 13: 632–634. - PubMed
-
- Allers K, Hutter G, Hofmann J, Loddenkemper C, Rieger K, et al. (2011) Evidence for the cure of HIV infection by CCR5Delta32/Delta32 stem cell transplantation. Blood 117: 2791–2799. - PubMed
-
- Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, et al. (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3: 1061–1068. - PubMed
-
- Casartelli N, Di Matteo G, Argentini C, Cancrini C, Bernardi S, et al. (2003) Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children. Aids 17: 1291–1301. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous